EX-10.1
Exhibit 10.1
RESTATED EMPLOYMENT AGREEMENT
THIS
RESTATED EMPLOYMENT AGREEMENT is made and entered into on this 28th day of July 2016, by and between Unilife Corporation (“Unilife”) and John C. Ryan (“Ryan”). The term
“Unilife” shall include its subsidiaries, affiliates, assigns and successors in interest under Sections 7, 8, and 13.
WHEREAS, Ryan and
Unilife are parties to an Employment Agreement dated September 15, 2014, as amended by agreements dated January 21, 2015, and October 13, 2015;
WHEREAS, Unilife is engaged in the business of designing, developing, manufacturing and supplying advanced drug delivery systems;
WHEREAS, Unilife has employed Ryan as Senior Vice President, General Counsel and Secretary since May 2014 and as Interim President and Chief Executive
Officer since March 2016;
WHEREAS, Unilife wishes to extend the employment of Ryan as President and Chief Executive Officer, and Ryan wishes to
extend the term of his employment with Unilife and serve as President and Chief Executive Officer
WHEREAS, contemporaneous with its approval of
this agreement, the Board of Directors of Unilife (the “Board”) has appointed Ryan to serve as a member of the Board to fill a pre-existing vacancy and intends for Ryan to continue to serve as a member of the Board for the duration of his
service as Unilife’s Chief Executive Officer; and
WHEREAS, Unilife and Ryan wish to enter into this restated employment agreement to set
forth the terms of Ryan’s continued employment relationship with Unilife.
NOW, THEREFORE, in consideration of the promises and covenants set
forth herein, and intending to be legally bound hereby, the parties restate all prior agreements concerning Ryan’s employment with Unilife, including the Employment Agreement dated September 15, 2014, as amended by agreements dated
January 21, 2015, and October 13, 2015, and agree as follows:
1. Term. This agreement shall be effective as of the date of this
agreement and shall be for a multi-year term commencing on such effective date and expiring on December 31, 2018. This agreement will automatically renew for one-year periods annually thereafter, unless either party gives the other party thirty
(30) days written notice in advance of the relevant expiration date of its intention not to renew the agreement. Upon expiration or earlier termination of this employment relationship, the provisions of this agreement will survive in accordance with
their terms or as otherwise necessary to fulfill their intended purposes. For avoidance of doubt, the rights and obligations of Unilife under Section 6 below shall remain in full force and effect until all payments due to him have been made to
Ryan and the rights and obligations of Ryan set forth in Sections 7 and 8 below shall remain in full force and effect and shall survive the expiration or termination of this agreement, regardless of the reason(s) for termination.
2. Position and Duties.
(a) Unilife
will employ Ryan as President and Chief Executive Officer and Ryan agrees to serve in such capacity for Unilife with responsibility, authority and duties typically held by an employee in such position. Ryan shall report to Unilife’s Board of
Directors with respect
to the performance of these duties and shall be a member of Unilife’s Executive Leadership Team. In the performance of these duties, Ryan shall devote his knowledge, skill, attention,
energies and all of his business time, and shall comply with all of Unilife’s policies, rules, and procedures, as they may be adopted or amended from time to time. Ryan shall not engage in any endeavor that would conflict with the
rendition of his services to Unilife, either directly or indirectly, without the prior written consent of Unilife’s Board Chair; provided, however, Ryan may participate in civic, charitable, educational, industry and professional organizations,
to the extent that such participation does not unreasonably interfere with the performance of his duties hereunder; and Ryan may also serve on corporate boards and committees, but only with the prior written consent of Unilife’s Board Chair and
to the extent permitted under Unilife’s Board Charter.
(b) Whenever, during his employment as Chief Executive Officer of Unilife,
Ryan’s term of service as a member of the Board expires, Unilife shall cause Ryan to be nominated for re-election to the Board and shall recommend such re-election to Unilife’s stockholders. Ryan shall not be entitled to any additional
compensation for his service as a director.
3. Compensation.
(a) Base Salary. Ryan shall be paid an annual base salary of four hundred fifty thousand Dollars ($450,000) payable in accordance with
Unilife’s standard payroll practices. Ryan’s base salary will be subject to the customary withholding and employment taxes, as required by law, with respect to compensation paid by an employer to an employee. At the discretion of
the Compensation Committee of the Board of Directors of Unilife (the “Compensation Committee”), Ryan shall be eligible for increases in base salary. Further, Unilife will not reduce Ryan’s base salary to less than what is agreed
to herein.
(b) Bonus. During the term of his employment hereunder, Ryan shall be eligible to earn an annual cash bonus pursuant to
Unilife’s Incentive Bonus Plan in amounts and percentages as determined by Unilife’s Compensation Committee. The target cash bonus opportunity for each year shall be no lower than sixty percent (60%) of base salary, and the maximum
cash bonus opportunity for each year shall be no lower than one hundred percent (100%) of base salary. Bonuses are subject to achievement of such goals and objectives as the Compensation Committee determines. Any bonus payable for a fiscal
or calendar year shall be paid in a lump-sum payment no later than the date that is two and one-half months after the close of the relevant fiscal or calendar year. Ryan’s bonuses will be subject to the customary withholding and employment
taxes, as required by law, with respect to compensation paid by an employer to an employee.
C Transaction and Retention Bonus.
Ryan shall be paid a transaction and retention bonus in the amount of four hundred thousand Dollars ($400,000) in recognition of Ryan’s critical role in Unilife’s exploration of strategic alternatives and entry into the strategic
collaboration with Amgen and his continued leadership following the closing of that transaction. Fifty percent ($200,000) of this transaction and retention bonus shall be paid upon the execution of this agreement and fifty percent ($200,000) of this
transaction and retention bonus shall be paid on December 15, 2016 provided that Ryan has not voluntarily resigned from his position other than for Good Reason.
-2-
4. Benefits.
(a) Benefits Generally Available to Unilife Employees. Ryan shall be eligible to participate in Unilife’s benefits programs
(including any equity incentive plan of Unilife or its affiliates), as they may change from time to time. The benefits provided to Ryan will be the same as the benefits provided to other similarly situated Unilife employees, and may be changed
upon expiration or other termination of the current benefits contracts. For further information, Ryan should review any applicable benefit plan documents, which will govern the terms of the benefits.
(b) Vacation. Ryan shall also receive four (4) weeks of paid vacation per calendar year. Any unused vacation days may be
carried over or paid in lieu thereof, to the extent allowed by Unilife’s policy for similarly situated employees.
(c) Equity
Plans. Any stock options and other stock-based awards that Ryan may receive from Unilife shall be governed by the applicable, underlying award agreement and the terms of the 2009 Stock Incentive Plan or any successor plan under which the
award is granted.
(d) Expenses. Unilife shall reimburse Ryan for all reasonable and necessary expenses incurred by him in
carrying out his duties under this agreement in accordance with Unilife’s business expense policies, including without limitation, requirements with respect to reporting, documentation and payment of such expenses. All such expenses shall
be paid promptly after submission in accordance with Unilife’s polices, but no later than December 31st of the calendar year following the year in which such expenses were incurred.
5. Indemnification. Both during and following his employment, Unilife agrees to provide Ryan with indemnification for acts performed in his
capacity as an employee, officer and/or director of Unilife (and to insurance coverage pursuant to Unilife’s Directors and Officers insurance policies, as in effect from time to time) equivalent to the indemnification and directors’ and
officers’ insurance coverage applicable to the then current officers and directors of Unilife.
6. Termination and Pay upon Termination.
(a) General Rule. In the event that (1) Unilife terminates this agreement and Ryan’s employment without Cause (as
defined herein) including employment termination due to Unilife’s election not to renew this agreement where Ryan was willing and able to continue performing services under the terms of this agreement, or (2) Ryan terminates this agreement and
Ryan’s employment for Good Reason (as defined herein), subject to Section 6(c) below, Unilife will pay or provide Ryan the severance benefits provided in subparagraphs (i) through (iv) of this Section 6(a).
(i) his base salary, at the rate in effect immediately before the date that Ryan’s employment terminates, for twelve (12)
months, in accordance with Unilife’s standard payroll practices then in effect, commencing on the fifteenth (15th) day after the date that Ryan’s employment terminates and the General
Release provided for in Section 9 of this Agreement becomes irrevocable;
(ii) provided that Ryan is eligible for and
timely elects to receive COBRA health, vision and dental care continuation coverage, the cost of Ryan’s COBRA health, vision and dental care continuation coverage premiums (for himself and his eligible dependents) for twelve (12) months,
commencing on the first of the month immediately after the month which includes the date that Ryan’s employment terminates and the General Release provided for in Section 9 of this agreement becomes irrevocable;
-3-
(iii) a lump sum payment equal to the greater of the amount of the annual
incentive bonus, if any, earned by Ryan for the last completed bonus year prior to the year in which his employment terminates or 60% of Ryan’s base salary as in effect immediately prior to his termination, which amount will be payable on the
fifteenth (15th) day after the date that Ryan’s employment terminates and the General Release provided for in Section 9 of this Agreement becomes irrevocable; and
(iv) all of Ryan’s outstanding time-vested stock options and other time-vested stock-based awards, if not otherwise fully
vested, shall then become fully vested.
(b) Other Terminations. If Ryan’s employment ceases for any reason other than as
described in Section 6(a), including Ryan’s election not to renew the agreement, Ryan shall not receive any compensation or benefits from the time of such cessation, except such compensation as was earned prior to that date, including, but not
limited to unused vacation and vested equity grants. In addition, Ryan agrees to provide Unilife with thirty (30) days advance written notice of his intent to terminate his employment, whether during the initial term or any renewal
thereof. Upon termination of this agreement, Ryan shall not have any further contact with any customers of Unilife on behalf of a competing entity until the expiration of the conditions of Section 8 of this agreement.
(c) Termination Following a Change in Control. If a cessation of employment described in Section 6(a) occurs during the 12
month period following a Change in Control, then for purposes of that cessation, the references in Sections 6(a)(i) and (ii) to “twelve (12) months” will in each case be replaced with a reference to “eighteen (18) months.”
(d) Concurrent Cessation of Board Service and Employment. Contemporaneous with any cessation of Ryan’s employment with
Unilife for any reason, unless otherwise requested by the Board, Ryan will resign from all officer and director positions with Unilife and its affiliates.
(e) Definitions.
(i) “Cause” will mean any one or more of the following:
(A) material neglect of assigned duties, willful misconduct in connection with the performance of duties, or refusal to perform
assigned duties (other than by reason of disability) which continues uncured for thirty (30) days following receipt of written notice of such neglect, misconduct or refusal from the Board, specifying the scope and nature of the deficiency;
(B) engaging in any act of dishonesty, any act of moral turpitude, any illegal conduct or committing a crime that causes
material harm to Unilife or its reputation;
(C) being barred from working in a Food and Drug Administration
(“FDA”) regulated industry by the FDA or otherwise being sanctioned by the FDA or any similar international body;
(D) breaching, in any material respect, the terms of any agreement with Unilife; or
(E) commencement of employment with any other employer while an employee of Unilife without the prior written consent of the
Board Chair.
-4-
(ii) “Change in Control” means a: (i) Change in Ownership
of Unilife Corporation, (ii) Change in Effective Control of Unilife Corporation, or a (iii) Change in the Ownership of Assets of Unilife Corporation, all as described herein and construed in accordance with Section 409A of the Internal Revenue
Code of 1986, as amended (the “Code”).
(A) A Change in Ownership of Unilife Corporation shall occur on the date
that any one Person acquires, or Persons Acting as a Group (or Group) acquire, ownership of the capital stock of Unilife Corporation that, together with the stock held by such Person or Group, constitutes more than fifty percent (50%) of the total
fair market value or total voting power of the capital stock of Unilife Corporation. However, if any one Person is, or Persons Acting as a Group are, considered to own more than fifty percent (50%) of the total fair market value or total voting
power of the capital stock of Unilife Corporation, the acquisition of additional stock by the same Person or Persons Acting as a Group is not considered to cause a Change in Ownership of Unilife Corporation or to cause a Change in Effective Control
of Unilife Corporation. An increase in the percentage of capital stock owned by any one Person, or Persons Acting as a Group, as a result of a transaction in which Unilife Corporation acquires its stock in exchange for property will be treated
as an acquisition of stock.
(B) A Change in Effective Control of Unilife Corporation shall occur on the date a majority of
members of the Board of Directors of Unilife Corporation is replaced during any twelve (12)-month period by directors whose appointment or election is not endorsed by a majority of the members of the Board of Directors of Unilife Corporation before
the date of the appointment or election.
(C) A Change in the Ownership of Assets of Unilife Corporation shall occur on the
date that any one Person acquires, or Persons Acting as a Group acquire (or has or have acquired during the twelve (12)-month period ending on the date of the most recent acquisition by such Person or Persons), assets (including tangible/real
property and intangible property (such as goodwill)) from Unilife Corporation the total gross fair market value of which is more than fifty percent (50%) of the total gross fair market value of all of the assets of Unilife Corporation immediately
before such acquisition or acquisitions. For this purpose, gross fair market value means the value of the assets of Unilife Corporation, or the value of the assets being disposed of, determined without regard to any liabilities associated with such
assets.
(D) The following rules of construction apply in interpreting the definition of Change in Control:
(I) A Person means any individual, entity or group within the meaning of Section 13(d) (3) or 14(d) (2) of the Securities
Exchange Act of 1934, as amended, other than employee benefit plans sponsored or maintained by Unilife Corporation and by entities controlled by Unilife Corporation or an underwriter of the capital stock of Unilife Corporation in a registered public
offering.
-5-
(II) Persons will be considered to be Persons Acting as a Group if they are
owners of a corporation that enters into a merger, consolidation, purchase or acquisition of stock, or similar business transaction with the corporation. If a Person owns stock in both corporations that enter into a merger, consolidation, purchase
or acquisition of stock, or similar transaction, such shareholder is considered to be acting as a Group with other shareholders only with respect to the ownership in that corporation before the transaction giving rise to the change and not with
respect to the ownership interest in the other corporation. Persons will not be considered to be acting as a Group solely because they purchase assets of the same corporation at the same time or purchase or own stock of the same corporation at the
same time, or as a result of the same public offering.
(III) For purposes of this Section 6(e), fair market value shall
be determined in accordance with Code Section 409A.
(IV) A Change in Control shall not include a transfer to a
related person as described in Code Section 409A or a public offering of capital stock of Unilife Corporation.
(E) For
purposes of this Section 6(e), Code Section 318(a) applies to determine stock ownership. Stock underlying a vested option is considered owned by the individual who holds the vested option (and the stock underlying an unvested option is not
considered owned by the individual who holds the unvested option). For purposes of the preceding sentence, however, if a vested option is exercisable for stock that is not substantially vested (as defined by Treasury Regulation §1.83-3(b)
and (j)), the stock underlying the option is not treated as owned by the individual who holds the option.
(iii)
“Good Reason” means any one or more of the following:
| |
(A) |
a material, adverse change in title, authority or duties (including the assignment of duties materially inconsistent with Ryan’s position as President and Chief Executive Officer, a failure of Unilife’s
stockholders to re-elect Ryan to serve as a member of the Board upon expiration his term of service thereon or removal of Ryan from the Board other than for Cause); |
| |
(B) |
a reduction in Ryan’s base salary or annual bonus opportunity below the levels set forth in Sections 3(a) and 3(b), respectively; |
| |
(C) |
a material breach of this agreement by Unilife; or |
| |
(D) |
the relocation of Ryan’s principal work location to a location more than 50 miles from Philadelphia, Pennsylvania. |
-6-
However, none of the foregoing events or conditions will constitute Good Reason unless Ryan
provides Unilife with written notice of the event or condition constituting Good Reason within 90 days following the occurrence thereof, Unilife does not reverse or otherwise cure the event or condition within 30 days of receiving such notice, and
Ryan resigns his employment within 180 days following the expiration of the applicable cure period.
7. Confidential Information.
(a) Ryan acknowledges that Unilife has a valuable property interest in all aspects of its business relationships with its customers, clients,
vendors and suppliers. In the course of Ryan’s work with Unilife, Ryan will become aware of and familiar with secret and confidential information of Unilife relating to its customers, clients, vendors and suppliers, and its internal
business operations. Secret and confidential information includes, but is not limited to, Unilife’s business plans, customer lists, customer data, marketing plans, supplier and vendor lists and cost information, software and computer
programs, data processing systems and information contained therein, financial statements, financial data, acquisition and divestiture plans, and any other trade secrets or confidential or proprietary information, documents, reports, plans, or data,
of or about Unilife that is not already available to the public or was known to Ryan prior to his employment with Unilife.
(b) Ryan
agrees that he will not, without the written consent of Unilife, during the term of this agreement or thereafter, disclose or make any use of secret and confidential information, except as may be required in the performance of his duties under
Section 2 of this agreement. Ryan agrees that, following the termination of his employment with Unilife for any reason, he will never use secret and confidential information to compete with Unilife in any manner, and he will never disclose
any secret and confidential information to any other business or individual, unless such secret or confidential information is: (i) publicly known through no breach of the provisions of this Section 7 by either party, (ii) lawfully disclosed by
a third party, or (iii) disclosed pursuant to legal requirement or court order. In no event shall any disclosure made to investment banking firms or private equity firms at the request of Unilife and as part of Ryan’s duties ever be
considered a violation of this Section 7.
(c) Upon termination of this agreement, Ryan shall surrender to Unilife all records and all
paper and/or electronic copies made of those records that pertain to any aspect of the business of Unilife, including all secret and confidential information.
8. Agreement Not To Compete.
(a)
In consideration for employment by Unilife and the benefits of this agreement, Ryan agrees to be bound by the covenant not to compete as set forth in Section 8 of this agreement below; provided however, this non-compete covenant will apply during
his employment and (i) for a period of two (2) years post-employment, if Ryan resigns his employment with Unilife without Good Reason, if Ryan’s employment ceases due to his election not to renew this agreement, or if Unilife terminates
Ryan’s employment for Cause, or (ii) for a period of one (1) year post-employment if Ryan’s employment with Unilife ceases under any other circumstance.
-7-
(b) Ryan agrees that during the term of his employment, he will not, directly or indirectly:
(i) render services to, become employed by, be engaged as a consultant by, own, or have a financial or other interest in
(either as an individual, partner, joint venture, owner, manager, employee, partner, officer, director, independent contractor, or other similar role) any business that is engaged in any business activity that is in direct competition with the
activities of Unilife, as of the date of the termination of this agreement.
(ii) induce, offer, assist, encourage, or
suggest that another business or enterprise offer employment to or enter into a consulting arrangement with any individual who is employed by Unilife, or induce, offer, assist, encourage, or suggest that any Unilife employee terminate his or her
employment with Unilife, or accept employment with any other business or enterprise.
(c) In the event that Ryan commits any breach of
Section 8(b) above, Ryan acknowledges that Unilife would suffer substantial and irreparable harm and damages. Accordingly, Ryan hereby agrees that in such event, Unilife shall be entitled to temporary and/or permanent injunctive relief, without
the necessity of proving damage, to enforce the provisions of this Section, all without prejudice to any and all other remedies that Unilife may have at law or in equity and that Unilife may elect or invoke. Ryan agrees that if any of the
provisions of this Section are or become unenforceable, the remainder hereof shall nevertheless remain binding upon him to the fullest extent possible, taking into consideration the purposes and spirit of this agreement. Any invalid or
unenforceable provision is to be reformed to the maximum time, geographic and/or business limitations permitted by applicable laws, so as to be valid and enforceable.
(d) Ryan expressly acknowledges and agrees that the restrictive covenants set forth in Sections 7 and 8 above are absolutely necessary to
protect the legitimate business interests of Unilife, because he is employed in a position of trust and confidence and is provided with extensive access to Unilife’s most confidential and proprietary trade secrets, and has significant
involvement in important business relationships, which constitute the goodwill of Unilife. Ryan further agrees and acknowledges that these restrictive covenants are reasonable, will not restrict him from earning a livelihood following the
termination of employment, and are intended by the parties to be enforceable following termination of employment for any reason.
(e) In
the event that Unilife must bring legal action to enforce or seek a remedy for any breach of the provisions of Sections 7 or 8 of this agreement and Ryan is found by a court to have breached any of these provisions, Ryan agrees to reimburse Unilife
for any and all expenses, including attorneys’ fees and court costs, incurred by it in enforcing the terms of these Sections of the agreement.
9. General Release. As a condition of receiving the severance compensation and benefits described in Section 6(a) or 6(c), Unilife and Ryan
will execute a mutual general release of claims (which is in a form acceptable to Unilife); provided that, to the extent that any claim that Unilife may have against Ryan would not be covered under the D&O insurance of Unilife, then Unilife
would not release such claim under the mutual release. Such general release would not include rights to previously vested options or claims for any compensation or benefits earned (including, without limitation, unused vacation), or
reimbursement of expenses incurred, through the date of termination. Such release must be agreed to, executed and irrevocable no later than 30 days following Ryan’s termination date.
-8-
10. Dispute Resolution. Any controversy, claim or dispute involving the parties (or their
affiliated persons) directly or indirectly concerning this agreement shall be finally settled by binding arbitration held in Montgomery County, Pennsylvania by one arbitrator (who is mutually acceptable to both parties as well as licensed to
practice law in the Commonwealth of Pennsylvania) in accordance with the rules of employment arbitration then followed by the American Arbitration Association or any successor to the functions thereof. The arbitrator shall apply Pennsylvania
law in the resolution of all controversies, claims and disputes and shall have the right and authority to determine how his or her decision or determination as to each issue or matter in dispute may be implemented or enforced. Any decision or
award of the arbitrator shall be final and conclusive for both Ryan and Unilife (and its affiliates), and there shall be no appeal there from other than causes of appeal allowed by the Federal Arbitration Act. Unilife shall bear all costs of
the arbitrator in any action brought under this agreement. The arbitrator shall have the power to award attorney’s fees and arbitration costs to the prevailing party, if the award of attorney’s fees and litigation costs would be
permitted by a court. The parties hereto agree that any action to compel arbitration may be brought in the appropriate Pennsylvania state or federal court, and in connection with such action to compel, the laws of the Commonwealth of
Pennsylvania and the Federal Arbitration Act shall control. Application may also be made to such court for confirmation of any decision or award of the arbitrator, for an order of the enforcement and for any other remedies, which may be
necessary to effectuate such decision or award. The parties hereto hereby consent to the jurisdiction of the arbitrator and of such court and waive any objection to the jurisdiction of such arbitrator and court.
11. Non-waiver. A waiver of any provision of this agreement by either party shall not prevent either party from enforcing that provision or
any other provision hereof.
12. Assignment. This agreement is personal and may not be assigned by Ryan. Any assignment of this
agreement between Unilife (or its successor) and its affiliates (and their successors) shall not constitute a termination of Ryan’s employment hereunder. This agreement (including the Restrictive Covenants set forth in Sections 7 and 8)
shall inure to the benefit of and be binding upon any successor to Unilife. The parties specifically understand and agree that the non-compete provisions of Section 8 will inure to the benefit of a successor and that Ryan will remain bound by
these provisions in the event of a sale or corporate reorganization of Unilife.
13. Severability. Each provision of this agreement is
severable and distinct from, and independent of, every other provision hereof. If one provision hereof is declared void, the remaining provisions shall remain in effect. Any provision of this agreement which is prohibited or unenforceable
in any jurisdiction shall, as to such jurisdiction, be ineffective only to the extent of such prohibition or unenforceability without invalidating or affecting the remaining provisions hereof, and any such prohibition or unenforceability in any
jurisdiction shall not invalidate or render unenforceable such provision in any other jurisdiction.
14. Entire Agreement. This agreement
contains the entire agreement of the parties concerning the employment relationship and supersedes any prior agreements or understandings between the parties concerning the terms and conditions of Ryan’s employment, whether oral or written;
provided, however, that Ryan’s equity grants shall be governed by the equity grant documents; provided further, that any stock options or other stock-based awards provided to Ryan shall be governed by Unilife’s stock incentive plans as
they are amended from time to time, except as provided herein. The parties acknowledge, in entering into this agreement that they have not relied upon any promise or inducement not specifically set forth herein. Any changes to this
agreement must be in writing and signed by both parties.
-9-
15. Section 409A.
(a) This agreement is intended to comply with, or otherwise be exempt from, Code Section 409A and any regulations and Treasury guidance
promulgated thereunder, and Unilife shall exercise its best efforts to interpret the terms of this agreement in a manner consistent with the requirements of Code Section 409A.
(b) Unilife shall undertake to administer this agreement in a manner that does not result in the imposition on Ryan of any additional tax,
penalty, or interest under Code Section 409A.
(c) Unilife and Ryan agree that they will execute any and all amendments to this agreement
permitted under applicable law as they mutually agree in good faith may be necessary to ensure compliance with the distribution provisions of Code Section 409A or as otherwise needed to ensure that this agreement complies with that section.
(d) The preceding provisions, however, shall not be construed as a guarantee by Unilife of any particular tax effect to Ryan under this
agreement. Unilife shall not be liable to Ryan for any payment made under this agreement that is determined to result in an additional tax, penalty, or interest under Code Section 409A, nor for reporting in good faith any payment made under
this agreement as an amount includible in gross income under that section.
(e) For purposes of Code Section 409A, the right to a series
of installment payments under this agreement shall be treated as a right to a series of separate payments.
(f) With respect to any
reimbursement of future expenses of, or any provision of in-kind benefits to, Ryan, as specified under this agreement, such reimbursement of expenses or provision of in-kind benefits shall be subject to the following conditions: (i) the expenses
eligible for reimbursement or the amount of in-kind benefits provided in one taxable year shall not affect the expenses eligible for reimbursement or the amount of in-kind benefits provided in any other taxable year, except for any medical
reimbursement arrangement providing for the reimbursement of expenses referred to in Code section 105(b); (ii) the reimbursement of an eligible expense shall be made no later than the end of the year after the year in which such expense was
incurred; and (iii) the right to reimbursement or in-kind benefits shall not be subject to liquidation or exchange for another benefit.
(g) “Termination of employment,” “resignation,” or words of similar import, as used in this agreement means, for purposes
of any payments under this agreement that are payments of deferred compensation subject to Code Section 409A, Ryan’s “separation from service” as defined in that section.
(h) If a payment obligation under this agreement arises on account of Ryan’s separation from service while Ryan is a “specified
employee” (as defined under Code Section 409A and determined in good faith by the Unilife), any such payment (i) constitutes “deferred compensation” (as defined under Treasury regulation section 1.409A-1(b)(1), after giving effect to
the exemptions in Treasury regulation sections 1.409A-1(b)(3) through (b)(12)), and (ii) is scheduled to be paid within six (6) months after such separation from service, such payment shall accrue without interest and shall be paid within 15 days
after the end of the six-month period beginning on the date of such separation from service or, if earlier, within 15 days after the appointment of the personal representative or executor of Ryan’s estate following his death.
-10-
(i) To the extent that under the terms of the agreement the execution of a general release of
claims is a condition to Ryan receiving severance or other benefits under the agreement, the Company will provide Ryan with the form of release agreement within seven days after Ryan’s separation from service. To be entitled to the
severance or other benefits, Ryan must execute and deliver to the Company the release agreement on or before the last day of the minimum required waiver consideration period provided under the Age Discrimination in Employment Act or other applicable
law or such other date as may be specified in the release agreement. If Ryan timely delivers an executed release agreement to the Company, and Ryan does not revoke the release agreement during the minimum revocation period required under
applicable law, if any, the severance or other benefits shall be paid or commence being paid, as applicable, on or after the date on which the release agreement becomes effective as specified in the agreement. If, however, the period during
which Ryan has discretion to execute or revoke the release agreement straddles two calendar years, then notwithstanding any other provision of this agreement, no such payment shall be made or benefit provided earlier than the first day of the second
such calendar year, regardless of within which calendar year Ryan actually delivers the executed release agreement to the Company. Consistent with Section 409A, Ryan may not, directly or indirectly, designate the calendar year of payment.
16. Excise Tax on Parachute Payments. Ryan shall bear all expense of, and be solely responsible for, all federal, state, local or foreign taxes
due with respect to any payment received hereunder, including, without limitation, any excise tax imposed by Code section 4999. Notwithstanding the foregoing, if any payment or distribution by Unilife to or for the benefit of Ryan, whether paid
or payable or distributed or distributable pursuant to the terms of this Agreement or otherwise pursuant to or by reason of any other agreement, policy, plan, program or arrangement or the lapse or termination of any restriction on or the vesting or
exercisability of any payment or benefit, would be subject to the excise tax imposed by Section 4999 of the Code (or any successor provision thereto) or to any similar tax imposed by state or local law (such tax or taxes are hereafter collectively
referred to as the “Excise Tax”), then the aggregate amount of such payments and benefits (each such payment or benefit, a “Payment”) payable to Ryan shall be reduced to the aggregate amount of Payments that may be made to
Ryan without incurring an Excise Tax in accordance with the immediately following sentence; provided that such reduction shall only be imposed if the net after-tax benefit of the Payments retained by Ryan (after giving effect to such
reduction) is equal to or greater than the net after-tax benefit (after giving effect to the Excise Tax) of the Payments to Ryan without any such reduction. If the Firm (as defined below) determines that a reduction is required by this Section
16, then such reduction shall be made in the following order: (i) first, any future cash payments (if any) shall be reduced (if necessary, to zero); (ii) second, any current cash payments shall be reduced (if necessary, to zero); (iii) third, all
non-cash payments (other than equity or equity derivative related payments) shall be reduced (if necessary, to zero); and (iv) fourth, all equity or equity derivative payments shall be reduced.
For purposes of this Section 16, “net after-tax benefit” shall mean (i) the total of all Payments which Ryan receives or is then
entitled to receive from Unilife, less (ii) the amount of all federal, state, local and foreign income taxes payable with respect to such Payment calculated at the maximum marginal income tax rate for each year in which the foregoing shall be paid
to Ryan (based on the rate in effect for such year as set forth in the Code or other applicable tax law as in effect at the time of the first payment of the foregoing), less (iii) the amount of the applicable Excise Tax, if any, imposed with respect
to the Payment.
-11-
The foregoing determination shall be made by a nationally recognized human resources consulting
or accounting firm (the “Firm”) selected by Unilife and reasonably acceptable to Ryan (which may be, but will not be required to be, Unilife’s independent auditors). The Firm shall submit its determination and detailed supporting
calculations to both Ryan and Unilife within fifteen (15) days after receipt of a notice from either Unilife or Ryan that Ryan may receive Payments
Ryan and Unilife shall each provide the Firm access to and copies of any books, records, and documents in the possession of Ryan or Unilife,
as the case may be, reasonably requested by the Firm, and otherwise cooperate with the Firm in connection with the preparation and issuance of the determinations and calculations contemplated by this Section 16. The fees and expenses of the
Firm for its services in connection with the determinations and calculations contemplated by this Section 16 shall be borne by Unilife.
17. Counterparts. This agreement may be executed on separate counterparts, each of which is deemed to be an original and all of which taken
together constitute one and the same agreement.
18. Interpretation. The captions and headings of this agreement are not part of the
provisions hereof and shall have no force or effect.
19. Notices. Any notices, requests, demands and other communications provided for
by this agreement shall be sufficient if in writing and if hand delivered, sent by overnight courier, or sent by registered or certified mail to Ryan at the last address he has filed in writing with Unilife or, in the case of Unilife, to
Unilife’s General Counsel at Unilife’s principal executive offices.
20. Governing Law. The terms of this agreement shall be
governed by and construed in accordance with the laws of the Commonwealth of Pennsylvania without giving effect to provisions thereof regarding conflict of laws.
21. Defend Trade Secrets Act Compliance. Ryan will not be held criminally or civilly liable under any federal or state trade secret law for his
disclosure of a trade secret that is made in confidence to federal, state or local government official or to an attorney, provided that such disclosure is: (a) solely for the purpose of reporting or investigating a suspected violation of law; or (b)
made in a complaint or other document filed in a lawsuit or other proceeding, if such filing is made under seal. If Ryan files a lawsuit for retaliation by Unilife for reporting a suspected violation of law, Ryan may disclose the trade secret
to his attorney and use the trade secret information in related court proceedings, provided that Ryan files any document containing the trade secret information under seal and does not disclose the trade secret, except pursuant to court order.
22. Representations and Warranties. Ryan represents and warrants to Unilife that he is not bound by any restrictive covenants and has no prior or
other obligations or commitments of any kind that would in any way prevent, restrict, hinder or interfere with Ryan’s employment or the performance of all duties and services hereunder to the fullest extent of Ryan’s ability and knowledge,
except for the duty of confidentiality owed to former employers. If Ryan has misrepresented the representation and warranty provided herein, then Ryan would be liable to Unilife for all damages incurred as a consequence thereof, including
attorney’s fees and costs of court.
-12-
[Remainder of the page left blank]
-13-
IN WITNESS WHEREOF, and wishing to be legally bound, the parties have executed this agreement on the date first
above written.
|
|
|
|
|
|
|
| UNILIFE CORPORATION: |
|
|
|
John C. Ryan: |
|
|
|
|
| By: |
|
/s/ Mary Katherine Wold |
|
|
|
/s/ John C. Ryan |
-14-
